
Overlap Results

Collection(s):	C2, C3
# overlaps shown:	10
# genesets in collections:	5574
# genes in comparison (n):	55
# genes in universe (N):	45956

Gene Set Name	# Genes in Gene Set (K)	Description	# Genes in Overlap (k)	k/K	p-value	FDR q-value
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	528	The 'group 1 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 and ERBB2 [GeneID=2099;2064].	7	0.0133	3.2E-6	8.55E-3
CAGGTG_E12_Q6	2485	Genes having at least one occurence of the highly conserved motif M12 CAGGTG sites. The motif matches transcription factor binding site V$E12_Q6 (v7.4 TRANSFAC).	13	0.0052	5.6E-6	8.55E-3
HAMAI_APOPTOSIS_VIA_TRAIL_UP	584	Genes up-regulated in T1 cells (primary melanoma, sensitive to TRAIL [GeneID=8743]) compared to G1 cells (metastatic melanoma, resistant to TRAIL).	7	0.0120	6.18E-6	8.55E-3
GGGCGGR_SP1_Q6	2940	Genes having at least one occurence of the highly conserved motif M6 GGGCGGR sites. The motif matches transcription factor binding site V$SP1_Q6 (v7.4 TRANSFAC).	14	0.0048	6.69E-6	8.55E-3
FISCHER_G2_M_CELL_CYCLE	225	Cell cycle genes with peak expression in G2/M check point.	5	0.0222	7.67E-6	8.55E-3
FOSTER_TOLERANT_MACROPHAGE_DN	409	Class NT (non-tolerizeable) genes: induced during the first LPS stimulation and induced at equal or greater degree in tolerant macrophages.	6	0.0147	9.61E-6	8.93E-3
ACEVEDO_LIVER_CANCER_UP	973	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	8	0.0082	1.98E-5	1.58E-2
BOYLAN_MULTIPLE_MYELOMA_C_UP	47	Genes up-regulated in group C of tumors arising from overexpression of BCL2L1 and MYC [GeneID=598;4609] in plasma cells.	3	0.0638	2.53E-5	1.77E-2
TACTTGA_MIR26A_MIR26B	300	Genes having at least one occurence of the motif TACTTGA in their 3' untranslated region. The motif represents putative target (that is, seed match) of human mature miRNAs hsa-miR-26a and hsa-miR-26b (v7.1 miRBase).	5	0.0167	3.05E-5	1.89E-2
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	307	The 'group 4 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 but not ERBB2 [GeneID=2099;2064].	5	0.0163	3.41E-5	1.9E-2


Gene/Gene Set Overlap Matrix

Entrez Gene Id	Gene Symbol	Gene Description	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	CAGGTG_E12_Q6	HAMAI_APOPTOSIS_VIA_TRAIL_UP	GGGCGGR_SP1_Q6	FISCHER_G2_M_CELL_CYCLE	FOSTER_TOLERANT_MACROPHAGE_DN	ACEVEDO_LIVER_CANCER_UP	BOYLAN_MULTIPLE_MYELOMA_C_UP	TACTTGA_MIR26A_MIR26B	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
10124	ARL4A	ADP-ribosylation factor-like 4A	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	CAGGTG_E12_Q6		GGGCGGR_SP1_Q6	FISCHER_G2_M_CELL_CYCLE	FOSTER_TOLERANT_MACROPHAGE_DN				
1952	CELSR2	cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila)	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	CAGGTG_E12_Q6								CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
5932	RBBP8	retinoblastoma binding protein 8	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1		HAMAI_APOPTOSIS_VIA_TRAIL_UP	GGGCGGR_SP1_Q6						CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
8204	NRIP1	nuclear receptor interacting protein 1	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1		HAMAI_APOPTOSIS_VIA_TRAIL_UP						TACTTGA_MIR26A_MIR26B	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
81539	SLC38A1	solute carrier family 38, member 1	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1			GGGCGGR_SP1_Q6						
55766	H2AFJ	H2A histone family, member J	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1									
79885	HDAC11	histone deacetylase 11	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1									
9912	ARHGAP44	Rho GTPase activating protein 44		CAGGTG_E12_Q6	HAMAI_APOPTOSIS_VIA_TRAIL_UP							
116113	FOXP4	forkhead box P4		CAGGTG_E12_Q6		GGGCGGR_SP1_Q6		FOSTER_TOLERANT_MACROPHAGE_DN		BOYLAN_MULTIPLE_MYELOMA_C_UP		
51582	AZIN1	antizyme inhibitor 1		CAGGTG_E12_Q6		GGGCGGR_SP1_Q6						
55182	RNF220	ring finger protein 220		CAGGTG_E12_Q6		GGGCGGR_SP1_Q6						
2969	GTF2I	general transcription factor IIi		CAGGTG_E12_Q6		GGGCGGR_SP1_Q6						
83541	FAM110A	family with sequence similarity 110, member A		CAGGTG_E12_Q6			FISCHER_G2_M_CELL_CYCLE			BOYLAN_MULTIPLE_MYELOMA_C_UP		
9334	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5		CAGGTG_E12_Q6				FOSTER_TOLERANT_MACROPHAGE_DN				
55604	LRRC16A	leucine rich repeat containing 16A		CAGGTG_E12_Q6						BOYLAN_MULTIPLE_MYELOMA_C_UP	TACTTGA_MIR26A_MIR26B	
64756	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1		CAGGTG_E12_Q6							TACTTGA_MIR26A_MIR26B	
64854	USP46	ubiquitin specific peptidase 46		CAGGTG_E12_Q6								
9397	NMT2	N-myristoyltransferase 2		CAGGTG_E12_Q6								
3685	ITGAV	integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)			HAMAI_APOPTOSIS_VIA_TRAIL_UP			FOSTER_TOLERANT_MACROPHAGE_DN	ACEVEDO_LIVER_CANCER_UP			
8411	EEA1	early endosome antigen 1			HAMAI_APOPTOSIS_VIA_TRAIL_UP							
51710	ZNF44	zinc finger protein 44			HAMAI_APOPTOSIS_VIA_TRAIL_UP							
103910	MYL12B	myosin, light chain 12B, regulatory			HAMAI_APOPTOSIS_VIA_TRAIL_UP							
387882	C12orf75	chromosome 12 open reading frame 75				GGGCGGR_SP1_Q6						CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
64598	MOSPD3	motile sperm domain containing 3				GGGCGGR_SP1_Q6						
4330	MN1	meningioma (disrupted in balanced translocation) 1				GGGCGGR_SP1_Q6						
81876	RAB1B	RAB1B, member RAS oncogene family				GGGCGGR_SP1_Q6						
5184	PEPD	peptidase D				GGGCGGR_SP1_Q6						
56886	UGGT1	UDP-glucose glycoprotein glucosyltransferase 1				GGGCGGR_SP1_Q6						
79660	PPP1R3B	protein phosphatase 1, regulatory subunit 3B				GGGCGGR_SP1_Q6						
167227	DCP2	DCP2 decapping enzyme homolog (S. cerevisiae)					FISCHER_G2_M_CELL_CYCLE	FOSTER_TOLERANT_MACROPHAGE_DN	ACEVEDO_LIVER_CANCER_UP			
3337	DNAJB1	DnaJ (Hsp40) homolog, subfamily B, member 1					FISCHER_G2_M_CELL_CYCLE		ACEVEDO_LIVER_CANCER_UP			
29957	SLC25A24	solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24					FISCHER_G2_M_CELL_CYCLE					CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
64332	NFKBIZ	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta						FOSTER_TOLERANT_MACROPHAGE_DN				
11275	KLHL2	kelch-like 2, Mayven (Drosophila)							ACEVEDO_LIVER_CANCER_UP			
1992	SERPINB1	serpin peptidase inhibitor, clade B (ovalbumin), member 1							ACEVEDO_LIVER_CANCER_UP			
10728	PTGES3	prostaglandin E synthase 3 (cytosolic)							ACEVEDO_LIVER_CANCER_UP			
5834	PYGB	phosphorylase, glycogen; brain							ACEVEDO_LIVER_CANCER_UP			
51522	TMEM14C	transmembrane protein 14C							ACEVEDO_LIVER_CANCER_UP			
9620	CELSR1	cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila)									TACTTGA_MIR26A_MIR26B	
9706	ULK2	unc-51-like kinase 2 (C. elegans)									TACTTGA_MIR26A_MIR26B	
147040	KCTD11	potassium channel tetramerisation domain containing 11										
5576	PRKAR2A	protein kinase, cAMP-dependent, regulatory, type II, alpha										
128866	CHMP4B	charged multivesicular body protein 4B										
9701	PPP6R2	protein phosphatase 6, regulatory subunit 2										
94097	SFXN5	sideroflexin 5										
162073	ITPRIPL2	inositol 1,4,5-trisphosphate receptor interacting protein-like 2										
84939	MUM1	melanoma associated antigen (mutated) 1										
10999	SLC27A4	solute carrier family 27 (fatty acid transporter), member 4										
151827	LRRC34	leucine rich repeat containing 34										
81543	LRRC3	leucine rich repeat containing 3										
7978	MTERF	mitochondrial transcription termination factor										
84259	DCUN1D5	DCN1, defective in cullin neddylation 1, domain containing 5 (S. cerevisiae)										
6891	TAP2	transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)										
7584	ZNF35	zinc finger protein 35										
84622	ZNF594	zinc finger protein 594										
